Frontlight ResearchEarly access
Brain metastases trials in Australia
8 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Not yet taking people in AustraliaPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- East Melbourne, Westmead
- Age
- 18 years and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - Phase 1/2Taking peopleBevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
- Where
- Melbourne
- Age
- 18 years and over
- People
- 46
- Run by
- Melanoma and Skin Cancer Trials Limited
See details and how to joinNCT06163820 - Phase 2Taking peopleAnti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
- Where
- Adelaide, East Melbourne, Melbourne, Perth, Sydney, Waratah, Wollstonecraft, Woolloongabba
- Age
- 18 years to 120 years
- People
- 218 worldwide
- Run by
- Melanoma Institute Australia
See details and how to joinNCT03340129 · EU 2024-518545-13-00 - No phaseTaking peopleTargeted Pediatric High-Grade Glioma Therapy
- Where
- Melbourne, Perth, Randwick, South Brisbane
- Age
- 12 months to 39 years
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - Phase 2Taking peopleStudy of Olutasidenib and Temozolomide in HGG
- Where
- Perth, Randwick, South Brisbane
- Age
- 12 years to 39 years
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - Phase 2Taking peopleStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- Melbourne, Perth, Randwick, South Brisbane
- Age
- 12 months to 39 years
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253 - Phase 1/2Taking peopleA Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- Where
- Frankston
- Age
- 18 years to 89 years
- People
- 130 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06907043 - No phaseNot yet taking people in AustraliaStudy Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer
- Where
- Melbourne
- Age
- 18 years and over
- People
- 45
- Run by
- Monash University
See details and how to joinNCT06728150